Total (N. = 135) N. % | Lap (N. = 60) N. % | Open (N. = 75) N. % | Chi-square test | P value | ||||
---|---|---|---|---|---|---|---|---|
Post operative GFR | Mean ± SD = 70.7 ± 17.5 | Mean ± SD = 68.7 ± 20.5 | Mean ± SD = 72.3 ± 14.7 | Student t test = 1.197 | < .001 (HS) | |||
PADUA score | Median (IQR) = 7 (6–9) | Median = 8 | IQR = 6–9 | Median = 7 | IQR = 6–8 | 2.118* | .034 (S) | |
Pain score | Median (IQR) = 8 (6–9) | Median = 7 | IQR = 6–8 | Median = 8 | IQR = 7–9 | 4.161* | < .001 (HS) | |
6 h pain score | Median (IQR) = (1–2) | Median = 1 | IQR = 1–2 | Median = 2 | IQR = 2–3 | 7.546* | < .001 (HS) | |
Stenting post operative | Yes | 17 12.6% | 4 | 6.7% | 5 | 6.7% | .000 | 1.0 |
No | 118 87.4% | 56 | 93.3% | 70 | 93.3% | |||
Blood transfusion | 100 ml | 8 5.9% | 0 | 0.0% | 8 | 10.7% | 7.165 | .028 (S) |
500 ml | 15 11.1% | 6 | 10.0% | 9 | 12.0% | |||
No | 112 83% | 54 | 90.0% | 58 | 77.3% | |||
Positive surgical margin | No | 127 94.1% | 54 | 90.0% | 73 | 97.3% | 3.891 | .143 |
Yes- surveillance every6 months for 2 years | 2 1.5% | 2 | 3.3% | 0 | 0.0% | |||
Yes- surveillance radical nephrectomy 10 months | 6 4.4% | 4 | 6.7% | 2 | 2.7% |